Uncovering the facts, Holding government accountable.
Published:March 27, 2020
FOIA to FDA Seeking Records Sufficient to Identify Date Gilead Submitted Orphan Drug Designation Request for COVID-19 Treatment
FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19. HHS-FDA-20-0718